Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Keytruda side effects liver?

See the DrugPatentWatch profile for Keytruda

What liver side effects does Keytruda cause?

Keytruda can trigger immune-mediated hepatitis, an inflammation of the liver that occurs when the drug activates the patient's immune system against healthy liver tissue. This occurs in roughly 0.7% to 3.3% of patients depending on the cancer type and treatment combination. Symptoms include fatigue, nausea, vomiting, upper-right abdominal pain, yellowing of the skin or eyes, and easy bruising.

How is liver toxicity managed when patients take Keytruda?

Doctors monitor liver function through blood tests before treatment starts and during every cycle. Abnormal results prompt immediate suspension of Keytruda. Steroids such as prednisone are prescribed at 1-2 mg/kg/day to calm the immune attack. Once the values return to normal, doctors may resume Keytruda at a lower dose or permanently discontinue it if severe damage persists.

What happens if liver tests show grade 3 or 4 toxicity?

Grade 3 or 4 liver enzyme elevations require permanent discontinuation of Keytruda. Patients receive high-dose corticosteroids and sometimes additional immunosuppressants. Follow-up liver tests continue until values stabilize. In rare cases, patients develop fulminant hepatitis that requires emergency transplant evaluation.

Why do liver tests get checked so oft



Other Questions About Keytruda :

Keytruda's fda approval can you name the year? What cancer did keytruda demonstrate initial effectiveness? In what year did keytruda gain fda approval for the first time? Can you recall the year keytruda was first approved by the fda for cancer therapy? When will the public have access to generic keytruda? How do keytruda's side effects compare to other immunotherapies? Can you name the year keytruda was approved by the fda?